Drug treatment of obesity in cardiovascular disease.

Drug treatment of obesity in cardiovascular disease.

Item
http://www.wikidata.org/entity/Q37980171
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesPost-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic reviewEffect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese miceα-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats.The Effect of Cumin cyminum L. Plus Lime Administration on Weight Loss and Metabolic Status in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Clinical Trial.Managing cardiovascular risk in overweight children and adolescents.Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
P2860

Drug treatment of obesity in cardiovascular disease.

Item
http://www.wikidata.org/entity/Q37980171
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug treatment of obesity in cardiovascular disease.
@en
Drug treatment of obesity in cardiovascular disease.
@nl
type
label
Drug treatment of obesity in cardiovascular disease.
@en
Drug treatment of obesity in cardiovascular disease.
@nl
prefLabel
Drug treatment of obesity in cardiovascular disease.
@en
Drug treatment of obesity in cardiovascular disease.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Drug treatment of obesity in cardiovascular disease.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11599000-000000000-00000
P433
P478
P50
P577
P6179
P698
P921